rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2007-5-2
|
pubmed:abstractText |
Our objective is to report the outcome of infliximab (IFX) in ulcerative colitis (UC) patients from a single center and to identify predictors of early clinical response.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1078-0998
|
pubmed:author |
pubmed-author:ArijsIngridI,
pubmed-author:De HertoghGertG,
pubmed-author:FerranteMarcM,
pubmed-author:GeboesJ KarelJK,
pubmed-author:HoffmanIlseI,
pubmed-author:KatsanosKonstantinos HKH,
pubmed-author:NomanMajaM,
pubmed-author:RutgeertsPaulP,
pubmed-author:SchnitzlerFabianF,
pubmed-author:Van AsscheGertG,
pubmed-author:VermeireSéverineS
|
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
123-8
|
pubmed:meshHeading |
pubmed-meshheading:17206703-Adolescent,
pubmed-meshheading:17206703-Adult,
pubmed-meshheading:17206703-Aged,
pubmed-meshheading:17206703-Aged, 80 and over,
pubmed-meshheading:17206703-Anti-Inflammatory Agents,
pubmed-meshheading:17206703-Antibodies, Monoclonal,
pubmed-meshheading:17206703-Azure Stains,
pubmed-meshheading:17206703-Child,
pubmed-meshheading:17206703-Colitis, Ulcerative,
pubmed-meshheading:17206703-Colonoscopy,
pubmed-meshheading:17206703-Female,
pubmed-meshheading:17206703-Gastrointestinal Agents,
pubmed-meshheading:17206703-Humans,
pubmed-meshheading:17206703-Male,
pubmed-meshheading:17206703-Middle Aged
|
pubmed:year |
2007
|
pubmed:articleTitle |
Predictors of early response to infliximab in patients with ulcerative colitis.
|
pubmed:affiliation |
Department of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium. marcferrante@yahoo.com
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|